Characterization of CK1δ-mediated phosphorylation of tau and development of novel pharmacological approaches targeting CK1δ in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2023
- Schlagwort
-
Signaltransduktion
Phosphorylierung
Proteinkinasen
Proteine
Proteinkinase CK1
Alzheimerkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2023
- Urheber
-
Roth, Aileen
- DOI
-
10.18725/OPARU-50254
- URN
-
urn:nbn:de:bsz:289-oparu-50330-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roth, Aileen
- Universität Ulm
Entstanden
- 2023
Ähnliche Objekte (12)
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz